Conversion From Brand to Generic Tacrolimus in High Risk Transplant Recipients

NCT02014103 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

71

Enrollment

OTHER

Sponsor class

Conditions

Complication of Transplant

Interventions

DRUG: Prograf
DRUG: Tacrolimus, Sandoz
DRUG: Tacrolimus, Reddy Laboratory
DRUG: Tacrolimus, Mylan
DRUG: Tacrolimus, Accord
DRUG: Tacrolimus, Pancea Biotech Limited

Sponsor

University of Cincinnati

Collaborators

[object Object]
[object Object]